Trial Profile
Effects of Eslicarbazepine Acetate (BIA 2-093) on Cognition and Psychomotor Function: Single-blind, Single-centre, Single and Multiple Dose, Fixed-order, Placebocontrolled Trial in Healthy Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 26 Dec 2014
Price :
$35
*
At a glance
- Drugs Eslicarbazepine acetate (Primary)
- Indications Epilepsy
- Focus Pharmacodynamics
- Sponsors Bial
- 11 Nov 2014 New trial record